ATF6 and cancer: The UPR, which is mediated by activating transcription factor 6 α (ATF6α), inositol requiring enzyme 1 alpha (IRE1α), and protein kinase R-like endoplasmic reticulum kinase (PERK) [15], has been implicated in chemoresistance and cancer development [13,16,17].